rofecoxib has been researched along with Allergic Encephalomyelitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ni, J | 1 |
| Shu, YY | 1 |
| Zhu, YN | 1 |
| Fu, YF | 1 |
| Tang, W | 1 |
| Zhong, XG | 1 |
| Wang, H | 1 |
| Yang, YF | 1 |
| Ren, J | 1 |
| Wang, MW | 1 |
| Zuo, JP | 1 |
1 other study available for rofecoxib and Allergic Encephalomyelitis
| Article | Year |
|---|---|
COX-2 inhibitors ameliorate experimental autoimmune encephalomyelitis through modulating IFN-gamma and IL-10 production by inhibiting T-bet expression.
Topics: Animals; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Diclofenac; Disease Models, Animal; Dose-R | 2007 |